Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 62.65% | -19.24% | 174.34% | 53.71% | -1.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 62.65% | -19.24% | 174.51% | 53.71% | -1.49% |
| Cost of Revenue | 63.95% | -11.85% | 295.54% | 19.15% | -6.60% |
| Gross Profit | 61.71% | -23.36% | 105.37% | 84.40% | 2.56% |
| SG&A Expenses | -2.27% | -10.12% | -27.32% | -2.00% | 20.19% |
| Depreciation & Amortization | 1,481.25% | 0.00% | 0.00% | 6.67% | 6.67% |
| Other Operating Expenses | -- | 283.77% | 300.66% | -276.11% | -- |
| Total Operating Expenses | 21.40% | 9.73% | 78.38% | -22.13% | 15.12% |
| Operating Income | 87.00% | -431.64% | -15.73% | 685.93% | -106.98% |
| Income Before Tax | 88.44% | -423.76% | -16.34% | 683.02% | -236.66% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 88.44% | -423.76% | -16.34% | 683.02% | -236.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.44% | -423.76% | -16.34% | 683.02% | -236.66% |
| EBIT | 87.00% | -431.64% | -15.73% | 685.93% | -106.98% |
| EBITDA | 100.82% | -420.07% | -15.83% | 698.02% | -108.47% |
| EPS Basic | 88.44% | -410.81% | 2.73% | 577.27% | -2,840.00% |
| Normalized Basic EPS | 88.44% | -413.04% | 2.63% | 412.70% | -2,885.00% |
| EPS Diluted | 88.44% | -410.81% | 2.73% | 577.27% | -2,840.00% |
| Normalized Diluted EPS | 88.44% | -413.04% | 2.63% | 412.70% | -2,885.00% |
| Average Basic Shares Outstanding | -0.05% | 5.25% | 19.39% | 21.99% | -88.59% |
| Average Diluted Shares Outstanding | -0.05% | 5.25% | 19.39% | 21.99% | -88.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |